US20070207321A1 - Method For Treating Surface Of Material, Surface-Treated Material, Medical Material, And Medical Instrument - Google Patents

Method For Treating Surface Of Material, Surface-Treated Material, Medical Material, And Medical Instrument Download PDF

Info

Publication number
US20070207321A1
US20070207321A1 US10594918 US59491805A US2007207321A1 US 20070207321 A1 US20070207321 A1 US 20070207321A1 US 10594918 US10594918 US 10594918 US 59491805 A US59491805 A US 59491805A US 2007207321 A1 US2007207321 A1 US 2007207321A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
material
surface
film
dlc
base
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10594918
Inventor
Yoshinori Abe
Tatsuyuki Nakatani
Keishi Okamoto
Kohei Shiraishi
Kazuo Sugiyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyo Advanced Technologies Co Ltd
Original Assignee
Toyo Advanced Technologies Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C16/00Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
    • C23C16/56After-treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/30Inorganic materials
    • A61L27/303Carbon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08Materials for coatings
    • A61L29/10Inorganic materials
    • A61L29/103Carbon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08Materials for coatings
    • A61L31/082Inorganic materials
    • A61L31/084Carbon; Graphite
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B32/00Carbon; Compounds thereof
    • C01B32/25Diamond
    • C01B32/28After-treatment, e.g. purification, irradiation, separation or recovery
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C16/00Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
    • C23C16/22Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the deposition of inorganic material, other than metallic material
    • C23C16/26Deposition of carbon only
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00389The prosthesis being coated or covered with a particular material
    • A61F2310/00574Coating or prosthesis-covering structure made of carbon, e.g. of pyrocarbon
    • A61F2310/0058Coating made of diamond or of diamond-like carbon DLC
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/31504Composite [nonstructural laminate]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/31504Composite [nonstructural laminate]
    • Y10T428/31511Of epoxy ether
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/31504Composite [nonstructural laminate]
    • Y10T428/3154Of fluorinated addition polymer from unsaturated monomers

Abstract

A diamond-like carbon film (DLC film) is formed on the surface of a base material made of an inorganic material, such as ceramics, or the like, or an organic material, such as resin, or the like. The surface of the resultant DLC film is treated with plasma, or the like, so as to be activated. Various monomers having biocompatibility, etc., are graft-polymerized to the activated surface of the DLC film, whereby a polymer layer is formed from the monomers grafted to the surface of the DLC film. Thus, the base material coated with the DLC film modified with a polymer which does not readily separate can be realized.

Description

    TECHNICAL FIELD
  • [0001]
    The present invention relates to a method for treating the surface of a material with a diamond-like carbon film formed thereon, a surface-treated material, a medical material having excellent biocompatibility, and a medical instrument.
  • BACKGROUND ART
  • [0002]
    The diamond-like carbon film (DLC film) has a hard, fine and inert surface. Therefore, when formed on the surface of a material, for example, an inorganic material, such as a metal, ceramic, etc., or an organic material, such as a resin, etc., the DLC film can give the surface of the material certain characteristics, such as abrasion resistance, corrosion resistance, surface smoothness, etc.
  • [0003]
    For example, it has been known that coating the surface of a mold or tool with a DLC film improves the durability and releasability. Further, the coating creates a very smooth and inert surface and therefore has been a promising surface treatment for materials of medical instruments which should not cause interactions with biosubstances (see, for example, Patent Document 1 and Non-Patent Document 1).
  • [0004]
    Meanwhile, modifying the surface of a material with various substances to achieve high functionality on the material surface has been studied. With this, for example, development of nanodevices for molecular recognition on a semiconductor surface modified with functionality components, development of antithrombotic medical materials where the surface of the materials is modified with an antithrombotic material.
  • [0005]
    Various studies have been conducted especially on the means for providing biocompatibility, such as antithrombogenicity, etc., to the surface of a medical material. For example, it has been known that a hydrogel layer similar to the surface of a biomembrane can be formed on the surface of a medical material by modifying the surface of the medical material with a polymer containing as one component an artificial material having a chemical structure similar to the components of the biomembrane, such as 2-methacryloyl-oxyethyl phosphorylcholine (MPC), o-methacryloyl-L-Serine (SerMA), or the like, whereby excellent biocompatibility can be given to the surface of the medical material.
  • [0006]
    The surface of the material which is to be modified by such a functionality component is preferably refractory and inert. When the material surface has high reactivity, there is a possibility that an interaction between the material surface and a functionality molecule as a modifier denatures and deactivates the modifier functionality component. Further, certain environments degrade the material itself. Therefore, a material coated with a very smooth, inert DLC film is expected to exhibit excellent quality as a material which is to be modified with a functionality component, etc.
  • [0007]
    [Patent Document 1] Japanese Laid-Open Patent Publication No. 10-248923
  • [0008]
    [Non-Patent Document 1] Haruo Ito et al., “Biomaterial”, 1985, Vol. 3, pp. 45-53
  • DISCLOSURE OF INVENTION Problems to be Solved by the Invention
  • [0009]
    However, the DLC film is smooth and inert and is therefore difficult to modify with a functionality component, such as a biocompatible material, or the like. Since the surface is very inert, it is almost impossible to cause a chemical reaction between the surface and a functionality component for generating a covalent bond therebetween. The very smooth surface is almost incapable of physical adsorption. Even if a functionality component is temporarily adsorbed by the surface, the component immediately separates from the surface.
  • [0010]
    The present invention provides a solution to the above-described problem. An objective of the present invention is to realize a material where a base material is coated with a DLC film stably modified for a long term with a functionality component, typically a biocompatible material, and a medical material having persistent, excellent biocompatibility.
  • Means for Solving the Problems
  • [0011]
    To achieve the above objective, according to the present invention, the base material is coated with a diamond-like carbon film (DLC film) to which a functionality component, typically a biocompatible material, is grafted.
  • [0012]
    Specifically, a material of the present invention includes: a diamond-like carbon film formed on a surface of a base material; and a polymer grafted to a surface of the diamond-like carbon film. Since the material of the present invention includes the polymer grafted to the surface of the DLC film, the polymer does not separate from the DLC film. Therefore, it is possible to modify the surface of the base material with the polymer stably for a long term.
  • [0013]
    The first medical material of the present invention includes a biocompatible component chemically bonded to a surface of a diamond-like carbon film formed on a surface of a base material.
  • [0014]
    According to the first medical material, the biocompatible component is bonded to the surface of the DLC film formed on the surface of the base material. Therefore, excellent biocompatibility can be given to the surface of the DLC film. The biocompatible component is chemically bonded to the surface of the DLC film and does not readily separate from the surface of the DLC film. Since the DLC film is capable of a hard, dense coating over the surface of various base materials, the DLC film itself does not separate, so that deterioration of the base material itself can be suppressed. As a result, it is possible to realize a medical material which exhibits stable biocompatibility for a long term such that the biocompatible component does not separate.
  • [0015]
    In the first medical material, the biocompatible component is preferably a polymer introduced by graft polymerization to the surface of the diamond-like carbon film.
  • [0016]
    With such a structure, it is possible to introduce a variety of freely designed molecules to the surface of the DLC film.
  • [0017]
    In the first medical material, the biocompatible component may be a polymer formed from vinylmonomers which contain fluorine and are grafted to the surface of the diamond-like carbon film, or may be a molecule containing silicon. The biocompatible component may be bonded by a covalent bond to the surface of the diamond-like carbon film or may be bonded by an ionic bond to the surface of the diamond-like carbon film. With such structures, it is possible to surely obtain a medical material in which separation of the biocompatible component from the DLC film does not occur.
  • [0018]
    In the first medical material, the biocompatible component preferably contains at least one functional group selected from a group consisting of an ethylene oxide group, a hydroxy group, a phosphate group, an amino group, an amido group, a phosphorylcholine group, a sulfone group, and a carboxyl group. With such functional groups contained, the biocompatibility can be surely given to the surface of the medical material.
  • [0019]
    In the first medical material, an intermediate layer may be provided between the base material and the diamond-like carbon film to improve adhesion between the base material and the diamond-like carbon film. With such a structure, the surface of the base material can be more firmly coated with the DLC film. The intermediate layer is preferably an amorphous film containing silicon and carbon as primary constituents.
  • [0020]
    The second medical material of the present invention includes a hydrophilic functional group introduced to a surface of a diamond-like carbon film formed on a surface of a base material. According to the second medical material, the hydrophilic functional group is introduced to the surface of the DLC film, so that the DLC film itself exhibits hydrophilicity. Therefore, it is possible to achieve a medical material which exhibits stable biocompatibility for a long term.
  • [0021]
    In the medical material of the present invention, the base material is preferably a metal material, ceramic material, or macromolecular material, or a complex thereof.
  • [0022]
    A medical instrument of the present invention is formed by using the medical material of the present invention. With such a structure, a medical instrument having excellent biocompatibility can be obtained.
  • [0023]
    The medical instrument of the present invention is preferably a medical instrument which is to be embedded in a living body. The medical instrument may be a catheter, guide wire, stent, artificial cardiovalvular membrane, or artificial joint.
  • [0024]
    The first material surface treating method of the present invention, includes: a diamond-like carbon film formation step of forming a diamond-like carbon film on a surface of a base material; an activation step of generating on a surface of the diamond-like carbon film a reactive region which serves as a polymerization starting point; and a polymerization step of polymerizing monomers using the polymerization starting point to graft the monomers to the surface of the diamond-like carbon film.
  • [0025]
    The first material surface treating method of the present invention includes the activation step of generating on a surface of the diamond-like carbon film a reactive region which serves as a polymerization starting point and the step of polymerizing monomers using the polymerization starting point. Therefore, it is possible to graft the polymer to the surface of the inert diamond-like carbon film. It is possible to modify the surface of the DLC film with the polymer stably for a long term. It is possible to give both the characteristics of the DLC film, such as durability, etc., and the characteristics of the polymer.
  • [0026]
    The first material surface treating method preferably includes, before the diamond-like carbon film formation step, an intermediate layer formation step of forming on the surface of the base material an intermediate layer for improving adhesion between the base material and the diamond-like carbon film. With this, it is possible to surely coat the surface of the base material with the DLC film. In the intermediate layer formation step, the intermediate layer is preferably formed of an amorphous film containing silicon and carbon as primary constituents.
  • [0027]
    In the first material surface treating method, the activation step is preferably the step of generating a free radical as the polymerization starting point. The activation step is preferably a plasma irradiation step of irradiating the surface of the diamond-like carbon film with plasma. With these features, the polymerization starting point can be surely generated on the surface of the DLC film. The plasma irradiation step preferably uses, as the plasma, argon, xenon, neon, helium, krypton, nitrogen, oxygen, ammonium, hydrogen, or water vapor.
  • [0028]
    In the first material surface treating method, the base material is preferably a base material for a medical material. The polymer is preferably a biocompatible component. With such features, a base material which exhibits stable biocompatibility for a long term can be obtained, and a medical material with excellent biocompatibility can be realized.
  • [0029]
    The second material surface treating method of the present invention includes: a diamond-like carbon film formation step of forming a diamond-like carbon film on a surface of a base material; a plasma irradiation step of irradiating a surface of the diamond-like carbon film with plasma to generate a reactive region on the surface of the diamond-like carbon film; and a surface modification step of causing a reaction of the reactive region and a molecule containing oxygen to introduce a hydroxy group to the surface of the diamond-like carbon film.
  • [0030]
    The second material surface treating method includes the plasma irradiation step of irradiating a surface of the diamond-like carbon film with plasma to generate a reactive region on the surface of the diamond-like carbon film, and the surface modification step of causing a reaction of the reactive region and a molecule containing oxygen to introduce a hydroxy group to the surface of the diamond-like carbon film. Therefore, it is possible to change the surface of the DLC film to be hydrophilic. It is possible to realize a material with excellent biocompatibility. Since the hydroxy group can be further substituted, it is possible to freely introduce a functional group to the surface of the DLC film and modify the surface with various compounds.
  • EFFECTS OF THE INVENTION
  • [0031]
    According to the present invention, a material wherein the surface of a base material is coated with a DLC film, and the DLC film is modified with a functionality component, typically a biocompatible material, stably for a long term, and a medical material and medical instrument with excellent biocompatibility can be realized.
  • BRIEF DESCRIPTION OF DRAWINGS
  • [0032]
    FIG. 1 is a schematic view of an ionic vapor deposition apparatus according to an embodiment of the present invention.
  • [0033]
    FIG. 2 is a schematic view of a plasma irradiation apparatus which is used for a medical material production method according to an embodiment of the present invention.
  • [0034]
    FIG. 3(a) and FIG. 3(b) show results of XPS measurement of the surface of a DLC film formed on a base material of aluminum based on a medical material production method according to an embodiment of the present invention. FIG. 3(a) shows the measurement result obtained before HMPA graft. FIG. 3(b) shows the measurement result obtained after HMPA graft.
  • DESCRIPTION OF REFERENCE NUMERALS
  • [0035]
    1 Substrate
  • [0036]
    2 Arc Discharge Plasma Generator
  • [0037]
    11 Base Material
  • [0038]
    21 Chamber
  • [0039]
    22 Vacuum Pump
  • [0040]
    23 Electrode
  • [0041]
    24 Electrode
  • [0042]
    25 High Frequency Power Supply
  • [0043]
    26 Matching Network
  • BEST MODE FOR CARRYING OUT THE INVENTION
  • [0044]
    The present inventors found that irradiating an inert DLC film, which has no reactivity in nature, with plasma, or the like, can activate the DLC film, so that monomers can be grafted to the surface of the DLC film by graft polymerization, or various functional groups can be introduced to the surface of the DLC film.
  • [0045]
    Thus, for example, after the surface of a DLC film formed on the surface of a base material, such as a metal, ceramic, resin, rubber, or the like, is activated, various functionality components are chemically bonded to the surface of the DLC film by means of graft polymerization, covalent bond, ionic bond, or the like, whereby the surface of the material is protected while various characteristics can be given to the material stably for a long term.
  • [0046]
    The present inventors also found that, when a biocompatible component is chemically bonded to the surface of the DLC film, a medical material which exhibits excellent biocompatibility for a long term can be realized wherein none of separation of the biocompatible component from the material surface and deterioration of the material occurs, and completed the present invention. Hereinafter, a structure of the present invention is described.
  • [0047]
    The base material used in the present invention is a metal material, a semiconductor material, such as silicon, or the like, a ceramic material, rubber, a polymeric material, such as a resin, or the like, or a complex thereof. The base material is subjected to various processes for medical uses, semiconductor uses, or other uses. For example, in medical uses, the base material of the present invention is used as a base material of a medical material used for manufacturing a medical instrument which comes in contact with a living body or organic component, typically a catheter, guide wire, stent, artificial cardiovalvular membrane, and artificial joint. The medical material includes materials used for medical instruments, such as wires, tubes, plates, etc., one that obtained by processing any of these materials in the shape of a medical instrument, and one that is in the midst of the formation of the medical instrument. As for semiconductor uses, the base material may be, for example, a semiconductor substrate which is a constituent of a semiconductor device.
  • [0048]
    Although the type of the base material is not limited to anything particular, a metal, such as iron, nickel, chrome, copper, titanium, platinum, tungsten, tantalum, or the like, can be used. Also, alloys of these metals, for example, stainless steel, such as SUS316L, or the like, a shape memory alloy, such as a Ti—Ni alloy, a Cu—Al—Mn alloy, or the like, other alloys, such as a Cu—Zn alloy, a Ni—Al alloy, a titanium alloy, a tantalum alloy, a platinum alloy, a tungsten alloy, or the like, can be used.
  • [0049]
    Alternatively, the base material may be a silicon or gallium semiconductor material, aluminum, silicon or zirconium oxide, silicon or zirconium nitride, ceramic or apatite, such as a carbide, or bioactive ceramic, such as bioglass, or the like. The base material may be a macromolecular resin, such as polymethyl methacrylate (PMMA), high density polyethylene, polyacetal, or the like, a silicon polymer, such as polydimethylsiloxane, or the like, or a fluoric polymer, such as polytetrafluoroethylene, or the like.
  • [0050]
    The DLC film formed on the surface of the base material is a film formed of diamond-like carbon (which may contain a very small amount of any other component as an impurity). This film is very smooth and inert in nature. However, free radicals or ion species can be generated by irradiating the surface of the DLC film with plasma, or the like, and cleaving some of diamond (carbon to carbon) bonds on the surface. Accordingly, a functionality component can be grafted by graft polymerization to the surface of the DLC film, or various functional groups can be introduced to the surface of the DLC film by means of reactions with various substances after activation.
  • [0051]
    Although the surface of the base material has irregularities on the order of microscale or nanoscale, formation of a DLC film on the surface of the base material can achieve a smooth surface. With the smooth surface, it is possible to uniformly irradiate the surface of the base material with plasma, so that uniform graft polymerization can be performed over the surface of the base material. Since the DLC film is a very dense and hard film, a foreign component can be prevented from permeating the DLC film and deteriorating the base material. Therefore, the material of the present invention can be used for a product used in an environment in which the acid resistance or alkali resistance is required or a product used in a living body.
  • [0052]
    In the present invention, the DLC film can be formed on the surface of the base material using a known method, such as sputtering, DC magnetron sputtering, RF magnetron sputtering, chemical vapor deposition (CVD), plasma CVD, plasma-based ion implantation, plasma-based ion implantation with superimposed RF and high-voltage pulses, ionic plating, arc ionic plating, ion beam deposition, laser ablation, or the like. The thickness of the DLC film is not limited to any particular thickness but is preferably in the range of 0.01 to 3 μm and, more preferably, in the range of 0.02 to 1 μm.
  • [0053]
    Although the DLC film can be directly formed on the surface of the base material, an intermediate layer may be provided between the base material and the DLC film for more firmly adhering the base material and the DLC film. The material of the intermediate layer can be selected among various materials according to the type of the base material. Any known material, such as an amorphous film of silicon (Si) and carbon (C), an amorphous film of titanium (Ti) and carbon (C), an amorphous film of chromium (Cr) and carbon (C), or the like, can be used for the intermediate layer. The thickness of the intermediate layer is not limited to any particular thickness but is preferably in the range of 0.005 to 0.3 μm and, more preferably, in the range of 0.01 to 0.1 μm.
  • [0054]
    The intermediate layer can be formed using a known method. For example, sputtering, CVD, plasma CVD, flame spraying, ionic plating, arc ionic plating, or the like, may be used.
  • [0055]
    According to the present invention, the surface of a DLC film is activated by energy irradiation on the DLC film with plasma, light, or the like, whereby a radical, ion, or the like, which serves as a polymerization starting point, can be generated on the surface of the DLC film. In the case of plasma irradiation, a gas capable of disconnecting a carbon to carbon bond present on the surface of the DLC film, such as argon (Ar), neon (Ne), helium (He), krypton (Kr), xenon (Xe), nitrogen gas (N2), oxygen gas (O2), ammonium gas (NH4), hydrogen gas (H2), water vapor (H2O), or the like, or a mixture gas thereof can be used as a plasma gas source. Alternatively, the surface of the DLC film can be activated by means of irradiation with ultraviolet light or ultraviolet ozone.
  • [0056]
    The activated surface of the DLC film has radicals, or the like, which serve as polymerization starting points. Therefore, various organic components can be grafted to the surface of the DLC film by graft-polymerizing various radical-polymerizable monomers on the activated surface of the DLC film. Therefore, an addition-polymerizable monomer, such as a vinylmonomer having the general formula of Formula 1, a vinylidene monomer having the general formula of Formula 2, a vinylene monomer having the general formula of Formula 3, a cyclic vinylene monomer having the general formula of Formula 4, or the like, can be graft-polymerized at a polymerization starting point generated on the surface of the DLC film.
  • [0057]
    Since the polymerization starting points can be generated on only part of the surface of the DLC film subjected to energy irradiation, a polymer can be introduced by graft polymerization only at a desired position over the surface of the base material using an appropriate mask. Further, the density of the polymer on the surface of the base material can be freely adjusted. For example, in the case where antithrombogenicity is given to the base material, the adjustment of the surface density of an antithrombotic macromolecular material grafted to the surface of the DLC film is important. According to the present invention, the surface density is readily adjustable.
    Figure US20070207321A1-20070906-C00001
  • [0058]
    In the monomer structures of Formula 1 to Formula 3, substituents X and Y are ester or amido, typically —COOR1, —CONR2, or the like. Substituents X and Y in the same molecule may be identical or may be different. In the monomer structure of Formula 4, substituent Z is ester or amido which is a constituent of a cyclic structure and typically is —CO—O—CO—, —CO—NR3—CO—, or the like.
  • [0059]
    Especially in the case where the material is applied to medical uses, R1 to R3 are each has a structure containing a highly biocompatible constituent, for example, a functional group, such as an ethyleneoxide group, hydroxy group, amino group, phosphorylcholine group, phosphate group, sulfone group, nucleobase, or the like, a monosaccharide, or a polysaccharide. It is preferably a molecule which forms a hydrogel layer at the interface with water when graft-polymerized.
  • [0060]
    Other than hydrophilic monomers, it may be a monomer containing dimethylsiloxane, fluorine, or the like, which is unlikely to adsorb protein and exhibits high hydrophobicity and biocomparibility.
  • [0061]
    Specifically, a known polymerizable monomer from which a biocompatible polymer is obtained when graft polymerized, such as 2-methacryloyl-oxyethyl phosphorylcholine (MPC), 2-acryloyl-oxyethyl phosphorylcholine, 1-methyl-2-methacryloyl-amideethyl phosphorylcholine, 2-glucoxy-oxyethyl methacryl acid, sulfated 2-glucoxy-oxyethyl methacryl acid, p-N-vinylbenzyl-D-lactone amide, p-N-vinylbenzyl-D-propione amide, p-N-vinylbenzyl-D-malto-trione amide, o-methacryloyl-L-serine, o-methacryloyl-L-threonine, o-methacryloyl-L-tyrosine, o-methacryloyl-L-hydroxyproline, 2-methoxyethyl methacryl amide, 2-methoxyethyl acryl amide, 2-hydroxyethyl acryl acid, N-2-hydroxypropyl methacryl amide, N-isopropyl acryl amide, N-vinylpyrrolidone, vinylphenol; N-2-hydroxy acryl amide, acryl amide derivative monomer, methacryl amide derivative monomer, phospholipid-like vinylmonomer, mocromonomer of polyethylenoxyde, or the like, can be used.
  • [0062]
    For example, a hydrogel layer, which has the function of inhibiting recognition of a foreign substance by a living body similarly to the surface of a biomembrane, can be formed on the surface of a DLC film by introducing MPC to the surface of the DLC film by graft polymerization. Since phospholipid present in blood is oriented/disposed on the basis of MPC grafted to the surface of the DLC film as a core, a function similar to that of the biomembrane can be given to the surface of the DLC film.
  • [0063]
    The above-listed monomers may be solely graft-polymerized or may be graft-polymerized in the form of a multidimensional copolymer. The graft polymerization may be performed at a single step or may be repeatedly performed in multi steps.
  • [0064]
    Although the optimum molecular weight of a polymer obtained by the graft polymerization depends on the use of the material, the type of a monomer to be grafted, etc., the component to be grafted to the surface is not limited to a macromolecule but may be an oligomer where the molecular weight of the polymer is 1000 or less. Especially when the material is applied to a medical use, the component may be one that the characteristics, such as the surface wettability of the material, etc., are changeable.
  • [0065]
    Although the above-described example uses radical polymerization, the graft can be achieved with anion polymerization or cation polymerization instead of radical polymerization by generating cation species or anion species as polymerization starting points on the surface of the DLC film. These polymerization starting points can be generated by means of low-temperature plasma irradiation, ultraviolet or ultraviolet ozone irradiation, γ-ray, or the like.
  • [0066]
    The method for modifying with a functionality component the surface of the DLC film which serves as a coating over the surface of the base material is not limited to the graft polymerization of monomers. For example, the technique of grafting a molecular chain may be employed wherein, for example, a functional group, such as an amino group, a carboxyl group, or the like, is introduced to the surface of the DLC film, and the functional group introduced to the surface of the DLC film and a functional group of the molecular chain are brought into a reaction.
  • [0067]
    The surface of the DLC film is activated by, for example, a plasma treatment so that an active point, such as a radical, or the like, is generated, and then, the active point is brought into a reaction with water or oxygen, whereby a hydroxy group can readily be introduced to the surface of the DLC film.
  • [0068]
    The hydroxy group introduced to the surface of the DLC film can readily be converted into an amino group, a carboxyl group, an isocyanate group, or a vinyl group by means of a reaction with a functional alkoxy silane derivative, such as 3-aminopropyltrimethoxysilane, or the like, a functional carboxylic acid, such as 2-mercaptoacetic acid, or the like, a diisocyanate derivative, 2-methacryloyl-oxyethyl isocyanate, 2-acryloyl-oxyethyl isocyanate, N-methacryloyl-succinimide, or N-acryloyl-succinimide. A functionality component containing in the molecule a functional group which cause a reaction with the functional group introduced to the surface of the DLC film, for example, an amino group, a carboxyl group, an isocyanate group, or a trialkyloxysilane group such as trimethoxysilane, triethoxysilane, etc., can readily be covalent-bonded to the surface of the DLC film. Even when the functionality component does not include a functional group which causes a direct reaction with the functional group on the surface of the DLC film, a functional group can be covalent-bonded to the surface of the DLC film by using a bifunctional reagent.
  • [0069]
    Especially when the material is applied to a medical use, a tissue-derived component having a functional group, such as peptide, protein, nucleobase, sugar chain, chitin, chitosan, or the like, or a biocompatible macromolecular chain including a hydroxy group, a carboxyl group, or amino group introduced by chain transfer reaction at a terminal may be brought into a coupling reaction with a functional group introduced to the surface of the DLC film in advance and fixed by covalent bond. The functionality component is not limited to a macromolecular chain but may be a low molecular component, such as an amino acid and a monosaccharide, and oligomers thereof. The reaction for converting the functional group is not limited to a single step reaction but may be a multi-step reaction. For example, the functional group may be converted in multi steps such that a hydroxy group is converted to an amino group and then to a vinyl group.
  • [0070]
    A biocompatible component may be introduced to the surface of the DLC film by forming an ionic bond between the surface of the DLC film and the biocompatible component using an ionic functional group present in the biocompatible component, such as a carboxyl group, amino group, phosphate group, or the like. In this case, the biocompatible component can readily be introduced to the surface of the DLC film even if it is an inorganic component, such as hydroxyapatite, or the like.
  • [0071]
    Biocompatibility may be given to the DLC film itself by introducing a functional group to the surface of the DLC film to alter the surface of the DLC film into a hydrophilic surface instead of introducing another biocompatible component to the surface of the DLC film.
  • EXAMPLE
  • [0072]
    Hereinafter, the present invention is described in more detail along with an example but is not limited to this example in any respect.
  • [0073]
    —Coating with DLC Film—
  • [0074]
    Coating of a DLC film over the base material is first described. In this example, an aluminum alloy (equivalent to JIS-8021 alloy) having a length of 50 mm, a width of 5 mm, and a thickness of 55 μm and polyethylene terephthalate (PET) were used for the base material.
  • [0075]
    FIG. 1 is a schematic view of an ionic vapor deposition apparatus used in this example. The ionic vapor deposition apparatus is a commonly-employed ionic vapor deposition apparatus wherein benzene (C6H6) gas is introduced as a carbon source into a DC arc discharge plasma generator 2 provided inside a vacuum chamber to generate plasma, and the generated plasma is collided with a substrate 1 biased to a negative voltage, which is a subject of the coating, whereby the plasma is solidified over the substrate 1 to form a film.
  • [0076]
    The base material was set inside the chamber of the ionic vapor deposition apparatus shown in FIG. 1, and argon gas (Ar) at the pressure of 10−3 to 10−5 Torr was introduced into the chamber, and then, a bombardment cleaning was carried out for about 30 minutes wherein Ar ions were generated by electric discharge, and the generated Ar ions were collided with the surface of the base material.
  • [0077]
    Then, tetramethylsilane (Si(CH3)4) was introduced into the chamber to form, as an intermediate layer, an amorphous film having a thickness of 0.02 μm to 0.05 μm containing silicon (Si) and carbon (C) as primary constituents.
  • [0078]
    After the formation of the intermediate layer, C6H6 gas was introduced into the chamber, and the gas pressure was set to 10−3 Torr. Electric discharge was performed while C6H6 was continuously introduced at the rate of 30 ml/min to ionize C6H6. Then, ionic vapor deposition was performed for about 10 minutes to form a DLC film having a thickness of 0.1 μm over the surface of the base material.
  • [0079]
    The formation of the DLC film was carried out under the following conditions: Substrate Voltage 1.5 kV, Substrate Current 50 mA, Filament Voltage 14 V, Filament Current 30 A, Anode Voltage 50V, Anode Current 0.6 A, Reflector Voltage 50 V, Reflector Current 6 mA. The temperature of the substrate was about 160° C.
  • [0080]
    The intermediate layer was provided for improving the adherence between the base material and the DLC film but may be omitted if sufficient adherence can be secured between the base material and the DLC film.
  • [0081]
    In this example, C6H6 gas was solely used as the carbon source, but mixture gas of C6H6 and fluorocarbon gas, such as CF4, or the like, may be used for forming a DLC film containing fluorine over the surface of the base material.
  • [0082]
    —Activation of DLC Film—
  • [0083]
    The DLC film formed over the surface of the base material was irradiated with plasma to activate the surface, and then a functionality component was grafted to the surface of the DLC film. FIG. 2 is a schematic view of a plasma irradiation apparatus used in this example.
  • [0084]
    As shown in FIG. 2, the plasma irradiation apparatus is a commonly-employed plasma irradiation apparatus wherein a chamber 21 formed by a separable flask, to which a vacuum pump 22 is connected and with which gas replacement is possible, is provided with electrodes 23 and 24 at the barrel and bottom, respectively, and a high frequency wave is applied to the electrodes through a matching network from a high frequency source 26 to generate plasma inside the chamber 21.
  • [0085]
    Firstly, the base material 11 with the DLC film formed thereon was set inside the chamber 21 of the plasma irradiation apparatus, and Ar gas was introduced so that the inner pressure of the chamber 21 was 1.3 Pa. Then, a high frequency wave of 20 W was applied to the electrodes 23 and 24 using the high frequency source 26 (JRF-300 manufactured by JEOL Ltd.; Frequency 13.56 MHz) to generate plasma inside the chamber 21. The DLC film formed on the base material 11 was irradiated with the plasma for about 2 minutes to produce radicals on the surface of the DLC film.
  • [0086]
    —Graft to DLC Film—
  • [0087]
    In this example illustrated herein, hydrophilic 2-hydroxypropyl methacryl amide (HPMA) was grafted to the activated DLC film.
  • [0088]
    After the plasma irradiation, the base material was exposed to air for about 1 minute and then inserted into a glass polymerization tube together with 10 ml of ethanol solution of HPMA (concentration: 0.17 g/ml). The cycle of freezing—deaeration—nitride replacement in liquid nitrogen was repeated several times to purge dissolved oxygen from the polymerization tube. Thereafter, the polymerization tube was sealed under a reduced pressure, and polymerization was carried out at 80° C. for 24 hours, whereby HPMA was graft-polymerized over the surface of the DLC film to graft the polymer of HPMA.
  • [0089]
    After the polymerization, the base material was immersed into an abundant amount of ethanol and then washed with an abundant amount of phosphoric acid buffer solution (pH=7.4) before freeze drying. As a result, a graft base material with a grafted HPMA polymer was obtained. It should be noted that, after the plasma irradiation, the base material is not necessarily exposed to air.
  • [0090]
    We measured the composition of elements present at the surface of the obtained graft base material using X-ray photoelectron spectroscopy (XPS) and confirmed introduction of HPMA. The XPS measurement was carried out using a XPS/ESCA apparatus, Model 5600 CiMC, manufactured by Perkin Elmer, Inc., and the X-ray source was a monochromatized Alkα (1486.5 eV) at the power of 100 w (14 kV, 7 mA). In the measurement, a neutralizer was used as a neutralizing electron gun, and the depth of the measurement was 4 nm.
  • [0091]
    FIG. 3 shows the results of XPS measurement of the distribution of elements present at the surface of a DLC film formed on a base material of aluminum. FIG. 3(a) shows the result of a base material surface measurement before a HPMA polymer was grafted. FIG. 3(b) shows the result of a base material surface measurement after the HPMA polymer was grafted.
  • [0092]
    Referring to FIG. 3(b), as for the DLC film surface after the HPMA polymer graft, we found the 1 s peak of nitrogen (N), which was not seen before the graft (FIG. 3(a)). The constitution ratio of carbon (C), oxygen (O), and nitrogen (N) obtained from the peak areas was C: 85.1%, O: 13.93%, N:0.89% before the graft, but C: 85.1%, O: 13.93%, N: 0.89% after the graft. That is, nitrogen (N) and oxygen (O) were greatly increased with respect to carbon (C). This indicates that a HPMA polymer was grafted to the surface of the DLC film and, as a result, an amido group was introduced to the surface of the DLC film.
  • [0093]
    We also grafted a HPMA polymer to a DLC film formed on a base material of PET and carried out the above-described measurement on this sample. We also found the Is peak of nitrogen after the HPMA polymer graft, which was not seen before the graft, and confirmed introduction of the HPMA polymer as in the case of the aluminum base material.
  • [0094]
    Then, the wettability of the surface of the obtained graft base material was measured using a contact angle measurement apparatus. The measurement of the contact angle was carried out using a goniometer-based contact angle measurement apparatus G-I manufactured by ERMA Inc.), wherein a water drop of 15 μl was placed on the surface of the medical material, and 50 seconds later, the left contact angle was measured, and 70 seconds later, the right contact angle was measured. The measurement value was the average of values at 10 measurement points.
  • [0095]
    In the case where a HPMA polymer was grafted to the surface of the DLC film formed on the aluminum base material, the contact angle of 67.8±3.50 before the graft of the HPMA polymer was decreased to 51.8±3.00 after the graft. This indicates that the HPMA polymer grafted to the surface of the DLC film changed the surface to be hydrophilic, thereby improving the biocompatibility of the graft base material.
  • [0096]
    In the case of the PET base material, the contact angle of 80.2±2.20 before the graft of the HPMA polymer was decreased to 52.1±2.50 after the graft. This indicates that the surface was changed to be hydrophilic as was in the case of the aluminum base material.
  • [0097]
    As described above, a polymer of HPMA is grafted to the surface of a DLC film formed on a medical material so that the surface of the DLC film becomes hydrophilic, whereby a hydrogel layer which inhibits foreign substance recognition by a living body is formed on the surface of the DLC film. Therefore, the biocompatibility of the medical material is improved. Since the HPMA polymer is introduced to the surface of the DLC film by graft polymerization so as not to readily separate, stable biocompatibility can be maintained for a long term.
  • [0098]
    By using the procedure of this example, a hydrophilic hydroxy group can be introduced to the surface of a DLC film. A DLC film was treated with plasma according to the procedure of this example and subjected to an exposure treatment in air for 2 minutes. The resultant sample was subjected to the XPS measurement and contact angle measurement. In the XPS measurement, we saw a C1s peak based on C—O bonds near 287 eV, which was not seen in an untreated DLC film, and confirmed introduction of a hydroxy group. The contact angle of 79.2±3.00 before the plasma treatment was decreased to 69.8±3.20 after the plasma treatment, which means an improvement in the wettability of the surface of the DLC film. This indicates that exposure of the plasma-treated DLC film to air caused a reaction of radicals produced at the surface of the DLC film and oxygen in air, whereby a hydroxy group was introduced to the surface of the DLC film.
  • [0099]
    As described above, according to the present invention, it is possible to cover the surface of a base material with an inert DLC film and freely modify the surface of the DLC film with various molecules. With this, it is possible not only to improve the durability of the base material but also to give a functionality of a molecule with which the surface of the DLC film is modified. For example, if the DLC film is modified with a molecule having the function of biocompatibility, a medical material which exhibits high durability and stable biocompatibility for a long term is obtained. Alternatively, by grafting stimuli-sensitive biocompatible gel to the surface of a DLC film, it is possible to achieve a cell culture material which causes less damage when separated or a highly-active bioreactor material.
  • [0100]
    Still alternatively, for example, the surface of a semiconductor substrate, such as a silicon, or the like, is coated with a DLC film, and then, a polymer is graft-polymerized to the DLC film, whereby the polymer is stably introduced to the surface of the semiconductor substrate. The resultant material can be used for an organic semiconductor device wherein molecular recognition is performed at the surface of the substrate. Since it is possible not only to perform the graft over the entire surface of the DLC film but also to perform the graft in an arbitrary pattern, the material can be applied to a microsensor which is used for measurement of a minute amount of substance, or the like.
  • INDUSTRIAL APPLICABILITY
  • [0101]
    According to a material surface treatment method, surface-treated material, medical material, and medical instrument of the present invention, a material with a coating of diamond-like carbon film can be realized wherein the surface of a base material is coated with a diamond-like carbon film, and the diamond-like carbon film is modified with a functionality component, such as a biocompatible component, or the like, stably for a long term. Therefore, the present invention is useful not only as a method for treating the surface of a material with a diamond-like carbon film formed thereon and a surface-treated material but also as a medical material with excellent biocompatibility and a medical instrument formed of the medical material. Further, it is possible to give the material a functionality other than biocompatibility. The present invention is also useful as a material for an organic semiconductor device, or the like.

Claims (23)

  1. 1. A material, comprising:
    a diamond-like carbon film formed on a surface of a base material; and
    a polymer grafted to a surface of the diamond-like carbon film.
  2. 2. A medical material comprising a biocompatible component chemically bonded to a surface of a diamond-like carbon film formed on a surface of a base material.
  3. 3. The medical material of claim 2, wherein the biocompatible component is a polymer introduced by graft polymerization to the surface of the diamond-like carbon film.
  4. 4. The medical material of claim 3, wherein the biocompatible component is a polymer formed by grafting vinylmonomers which contain fluorine to the surface of the diamond-like carbon film.
  5. 5. The medical material of claim 3, wherein the biocompatible component is a molecule containing silicon, the molecule being grafted to the surface of the diamond-like carbon film.
  6. 6. The medical material of claim 2, wherein the biocompatible component is bonded by a covalent bond to the surface of the diamond-like carbon film.
  7. 7. The medical material of claim 2, wherein the biocompatible component is bonded by an ionic bond to the surface of the diamond-like carbon film.
  8. 8. The medical material of claim 2, wherein the biocompatible component contains at least one functional group selected from a group consisting of an ethylene oxide group, a hydroxy group, a phosphate group, an amino group, an amido group, a phosphorylcholine group, a sulfone group, and a carboxyl group.
  9. 9. The medical material of claim 2, wherein an intermediate layer is provided between the base material and the diamond-like carbon film to improve adhesion between the base material and the diamond-like carbon film.
  10. 10. The medical material of claim 9, wherein the intermediate layer is an amorphous film containing silicon and carbon as primary constituents.
  11. 11. A medical material, comprising a hydrophilic functional group introduced to a surface of a diamond-like carbon film formed on a surface of a base material.
  12. 12. The medical material of claim 2, wherein the base material is a metal material, ceramic material, or macromolecular material, or a complex thereof.
  13. 13. A medical instrument formed by using the medical material of claim 2.
  14. 14. The medical instrument of claim 13, wherein the medical instrument is a medical instrument which is to be embedded in a living body.
  15. 15. The medical instrument of claim 14, wherein the medical instrument is a catheter, guide wire, stent, artificial cardiovalvular membrane, or artificial joint.
  16. 16. A material surface treating method, comprising:
    a diamond-like carbon film formation step of forming a diamond-like carbon film on a surface of a base material;
    an activation step of generating on a surface of the diamond-like carbon film a reactive region which serves as a polymerization starting point; and
    a polymerization step of polymerizing monomers using the polymerization starting point to graft the monomers to the surface of the diamond-like carbon film.
  17. 17. The method of claim 16 further comprising, before the diamond-like carbon film formation step, an intermediate layer formation step of forming on the surface of the base material an intermediate layer for improving adhesion between the base material and the diamond-like carbon film.
  18. 18. The method of claim 17 wherein, in the intermediate layer formation step, the intermediate layer is formed of an amorphous film containing silicon and carbon as primary constituents.
  19. 19. The method of claim 16, wherein the activation step is the step of generating a free radical as the polymerization starting point.
  20. 20. The method of claim 16, wherein the activation step is a plasma irradiation step of irradiating the surface of the diamond-like carbon film with plasma.
  21. 21. The method of claim 20, wherein the plasma irradiation step uses, as the plasma, argon, xenon, neon, helium, krypton, nitrogen, oxygen, ammonium, hydrogen, or water vapor.
  22. 22. The method of claim 16, wherein:
    the base material is a base material for a medical material; and
    the polymer is a biocompatible component.
  23. 23. A material surface treating method, comprising:
    a diamond-like carbon film formation step of forming a diamond-like carbon film on a surface of a base material;
    a plasma irradiation step of irradiating a surface of the diamond-like carbon film with plasma to generate a reactive region on the surface of the diamond-like carbon film; and
    a surface modification step of a reaction of the reactive region and a molecule containing oxygen to introduce a hydroxy group to the surface of the diamond-like carbon film.
US10594918 2004-03-30 2005-03-25 Method For Treating Surface Of Material, Surface-Treated Material, Medical Material, And Medical Instrument Abandoned US20070207321A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2004-100186 2004-03-30
JP2004100186 2004-03-30
PCT/JP2005/005534 WO2005097673A1 (en) 2004-03-30 2005-03-25 Method for treating surface of base, surface-treated base, material for medical use and instrument for medical use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12088000 US8435287B2 (en) 2004-03-30 2007-01-15 Stent and method for fabricating the same
US12697581 US8221823B2 (en) 2004-03-30 2010-02-01 Method for fabricating material

Publications (1)

Publication Number Publication Date
US20070207321A1 true true US20070207321A1 (en) 2007-09-06

Family

ID=35124965

Family Applications (2)

Application Number Title Priority Date Filing Date
US10594918 Abandoned US20070207321A1 (en) 2004-03-30 2005-03-25 Method For Treating Surface Of Material, Surface-Treated Material, Medical Material, And Medical Instrument
US12697581 Active 2025-11-29 US8221823B2 (en) 2004-03-30 2010-02-01 Method for fabricating material

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12697581 Active 2025-11-29 US8221823B2 (en) 2004-03-30 2010-02-01 Method for fabricating material

Country Status (7)

Country Link
US (2) US20070207321A1 (en)
EP (1) EP1754684B1 (en)
JP (2) JP4838709B2 (en)
KR (1) KR20070116191A (en)
CN (1) CN1938224B (en)
CA (1) CA2561667C (en)
WO (1) WO2005097673A1 (en)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070246233A1 (en) * 2006-04-04 2007-10-25 Johnson A D Thermal actuator for fire protection sprinkler head
US20090005862A1 (en) * 2004-03-30 2009-01-01 Tatsuyuki Nakatani Stent and Method For Fabricating the Same
US20090035859A1 (en) * 2007-07-30 2009-02-05 Alfred David Johnson Method and devices for preventing restenosis in cardiovascular stents
WO2009073609A1 (en) * 2007-11-30 2009-06-11 Tini Alloy Company Biocompatible copper-based single-crystal shape memory alloys
US20090209942A1 (en) * 2006-05-17 2009-08-20 Tatsuyuki Nakatani Medical device having diamond-like thin film and method for manufacturing thereof
US7763342B2 (en) 2005-03-31 2010-07-27 Tini Alloy Company Tear-resistant thin film methods of fabrication
EP2221274A1 (en) * 2007-11-07 2010-08-25 Toyo Advanced Technologies Co., Ltd. Carbonaceous thin film and manufacturing method for same
US7842143B2 (en) 2007-12-03 2010-11-30 Tini Alloy Company Hyperelastic shape setting devices and fabrication methods
US20110122486A1 (en) * 2007-02-23 2011-05-26 Technische Universität Kaiserslautern Plasma-Deposited Electrically Insulating, Diffusion-Resistant and Elastic Layer System
US20110171817A1 (en) * 2010-01-12 2011-07-14 Axcelis Technologies, Inc. Aromatic Molecular Carbon Implantation Processes
US8349099B1 (en) 2006-12-01 2013-01-08 Ormco Corporation Method of alloying reactive components
US8382917B2 (en) 2007-12-03 2013-02-26 Ormco Corporation Hyperelastic shape setting devices and fabrication methods
US20130070366A1 (en) * 2011-09-21 2013-03-21 Hitachi Global Storage Technologies Netherlands B.V. Magnetic recording head with low-wear protective film having hydrogen and/or water vapor therein
US20130282137A1 (en) * 2010-06-28 2013-10-24 Cyril Voisard Coated implant
US8584767B2 (en) 2007-01-25 2013-11-19 Tini Alloy Company Sprinkler valve with active actuation
US8684101B2 (en) 2007-01-25 2014-04-01 Tini Alloy Company Frangible shape memory alloy fire sprinkler valve actuator
US20140170331A1 (en) * 2006-03-29 2014-06-19 Kyocera Medical Corporation Biomaterial, joint prosthesis using the biomaterial and method of producing the same
US9192694B2 (en) 2007-10-03 2015-11-24 Kyocera Medical Corporation Biocompatible and low-abrasion member, and artificial joint using the same and method of producing the same
US20160281216A1 (en) * 2013-03-19 2016-09-29 Taiyo Yuden Chemical Technology Co., Ltd. Structure having stain-proofing amorphous carbon film and method of forming stain-proofing amorphous carbon film

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7713297B2 (en) 1998-04-11 2010-05-11 Boston Scientific Scimed, Inc. Drug-releasing stent with ceramic-containing layer
JP2007195883A (en) * 2006-01-30 2007-08-09 Japan Stent Technology Co Ltd Stent and its production method
US9526814B2 (en) * 2006-02-16 2016-12-27 Boston Scientific Scimed, Inc. Medical balloons and methods of making the same
US20070191931A1 (en) * 2006-02-16 2007-08-16 Jan Weber Bioerodible endoprostheses and methods of making the same
WO2007106438A3 (en) * 2006-03-10 2007-12-27 Versilant Nanotechnologies Llc Methods of manufacturing highly polished gemstones
EP1997620B1 (en) * 2006-03-17 2016-06-15 National Institute of Advanced Industrial Science and Technology Laminated body and carbon film deposition method
US20070224235A1 (en) 2006-03-24 2007-09-27 Barron Tenney Medical devices having nanoporous coatings for controlled therapeutic agent delivery
US8187620B2 (en) 2006-03-27 2012-05-29 Boston Scientific Scimed, Inc. Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents
US8128688B2 (en) * 2006-06-27 2012-03-06 Abbott Cardiovascular Systems Inc. Carbon coating on an implantable device
US8815275B2 (en) 2006-06-28 2014-08-26 Boston Scientific Scimed, Inc. Coatings for medical devices comprising a therapeutic agent and a metallic material
US8771343B2 (en) 2006-06-29 2014-07-08 Boston Scientific Scimed, Inc. Medical devices with selective titanium oxide coatings
KR100787891B1 (en) 2006-09-04 2007-12-27 한국생산기술연구원 Thin film manufacturing method by plasma chemical deposition
JP2010503469A (en) 2006-09-14 2010-02-04 ボストン サイエンティフィック リミテッド Medical device having a drug eluting coating
US20080069858A1 (en) * 2006-09-20 2008-03-20 Boston Scientific Scimed, Inc. Medical devices having biodegradable polymeric regions with overlying hard, thin layers
US7981150B2 (en) 2006-11-09 2011-07-19 Boston Scientific Scimed, Inc. Endoprosthesis with coatings
JP5213351B2 (en) * 2006-11-28 2013-06-19 株式会社朝日ラバー Adhesive base and a silicone rubber bonded object using the same
US8431149B2 (en) 2007-03-01 2013-04-30 Boston Scientific Scimed, Inc. Coated medical devices for abluminal drug delivery
US8070797B2 (en) 2007-03-01 2011-12-06 Boston Scientific Scimed, Inc. Medical device with a porous surface for delivery of a therapeutic agent
JP5172180B2 (en) * 2007-03-19 2013-03-27 トーヨーエイテック株式会社 Modification method and Dlc film, medical materials, method for producing the medical instrument
US8067054B2 (en) 2007-04-05 2011-11-29 Boston Scientific Scimed, Inc. Stents with ceramic drug reservoir layer and methods of making and using the same
US7976915B2 (en) 2007-05-23 2011-07-12 Boston Scientific Scimed, Inc. Endoprosthesis with select ceramic morphology
US7942926B2 (en) 2007-07-11 2011-05-17 Boston Scientific Scimed, Inc. Endoprosthesis coating
US8002823B2 (en) 2007-07-11 2011-08-23 Boston Scientific Scimed, Inc. Endoprosthesis coating
US9284409B2 (en) 2007-07-19 2016-03-15 Boston Scientific Scimed, Inc. Endoprosthesis having a non-fouling surface
US8815273B2 (en) 2007-07-27 2014-08-26 Boston Scientific Scimed, Inc. Drug eluting medical devices having porous layers
US7931683B2 (en) 2007-07-27 2011-04-26 Boston Scientific Scimed, Inc. Articles having ceramic coated surfaces
US8221822B2 (en) 2007-07-31 2012-07-17 Boston Scientific Scimed, Inc. Medical device coating by laser cladding
WO2009020520A1 (en) 2007-08-03 2009-02-12 Boston Scientific Scimed, Inc. Coating for medical device having increased surface area
JP5066768B2 (en) * 2007-09-07 2012-11-07 トーヨーエイテック株式会社 Modified carbon membrane
WO2009038180A1 (en) * 2007-09-21 2009-03-26 Kyushu University, National University Corporation Tissue-bondable material for medical use
JP2009082257A (en) * 2007-09-28 2009-04-23 Japan Stent Technology Co Ltd Medical equipment having lubricative surface and its manufacturing method
US8216632B2 (en) 2007-11-02 2012-07-10 Boston Scientific Scimed, Inc. Endoprosthesis coating
US7938855B2 (en) 2007-11-02 2011-05-10 Boston Scientific Scimed, Inc. Deformable underlayer for stent
US8029554B2 (en) 2007-11-02 2011-10-04 Boston Scientific Scimed, Inc. Stent with embedded material
JP5215653B2 (en) * 2007-12-25 2013-06-19 学校法人東海大学 Antithrombotic materials and manufacturing method thereof
KR101033166B1 (en) 2008-04-08 2011-05-11 한국과학기술연구원 Silicon incorporated diamond-like carbon film having a good hemocompatibility of biomedical material and the fabrication method thereof, and biomedical material using the same
US8920491B2 (en) 2008-04-22 2014-12-30 Boston Scientific Scimed, Inc. Medical devices having a coating of inorganic material
WO2009132176A3 (en) 2008-04-24 2010-09-02 Boston Scientific Scimed, Inc. Medical devices having inorganic particle layers
WO2009155328A3 (en) 2008-06-18 2010-09-16 Boston Scientific Scimed, Inc. Endoprosthesis coating
JP5659362B2 (en) * 2008-06-24 2015-01-28 学校法人東海大学 Endothelial cell proliferation resistant material
US8231980B2 (en) 2008-12-03 2012-07-31 Boston Scientific Scimed, Inc. Medical implants including iridium oxide
US8071156B2 (en) 2009-03-04 2011-12-06 Boston Scientific Scimed, Inc. Endoprostheses
JP5363159B2 (en) * 2009-03-27 2013-12-11 トーヨーエイテック株式会社 Carbonaceous film and a manufacturing method thereof
US8287937B2 (en) 2009-04-24 2012-10-16 Boston Scientific Scimed, Inc. Endoprosthese
US20120190114A1 (en) * 2009-10-08 2012-07-26 Korea Institute Of Science And Technology Silicon-incorporated diamond-like carbon film, fabrication method thereof, and its use
CN102892706B (en) 2010-03-03 2015-08-12 太阳化学工业株式会社 In the immobilization method consisting of the amorphous carbon layer, and the laminate
JP5806289B2 (en) 2010-04-06 2015-11-10 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Endoprosthesis
KR101052729B1 (en) * 2010-11-16 2011-07-29 트인로드 주식회사 Fabric coated with dlc(diamond like carbon) film, device and method for manufacturing the same
JP5775366B2 (en) * 2011-06-06 2015-09-09 積水化学工業株式会社 Method for manufacturing a polymer composite material - a carbon material
JP2015501163A (en) * 2011-09-15 2015-01-15 エーメディカ コーポレーション Coated implants and related methods
JP6133017B2 (en) * 2012-04-27 2017-05-24 京セラメディカル株式会社 Method for producing a film manufacturing apparatus and prosthesis components
JP5536168B2 (en) * 2012-10-03 2014-07-02 トーヨーエイテック株式会社 Superhydrophilic material, medical material and medical instruments
KR101586690B1 (en) * 2013-12-23 2016-01-19 주식회사 에스에프에이 Sputter system
CN104056307B (en) * 2014-05-29 2016-05-11 深圳市信立泰生物医疗工程有限公司 A developing biodegradable polymer scaffold and preparation method

Citations (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026607A (en) * 1989-06-23 1991-06-25 C. R. Bard, Inc. Medical apparatus having protective, lubricious coating
US5489303A (en) * 1991-01-25 1996-02-06 Terumo Kabushiki Kaisha Biocompatible material for medical apparatus comprising hydrophobically bound oil-soluble vitamin
US5763072A (en) * 1994-12-23 1998-06-09 Maruwa Ceramic Co., Ltd. Ceramic sliding member having pyrolytic carbon film and process of fabricating the same
US5932299A (en) * 1996-04-23 1999-08-03 Katoot; Mohammad W. Method for modifying the surface of an object
US5981297A (en) * 1997-02-05 1999-11-09 The United States Of America As Represented By The Secretary Of The Navy Biosensor using magnetically-detected label
US6083570A (en) * 1987-03-31 2000-07-04 Lemelson; Jerome H. Synthetic diamond coatings with intermediate amorphous metal bonding layers and methods of applying such coatings
US6159531A (en) * 1999-08-30 2000-12-12 Cardiovasc, Inc. Coating having biological activity and medical implant having surface carrying the same and method
US6197120B1 (en) * 1997-11-26 2001-03-06 3M Innovative Properties Company Apparatus for coating diamond-like networks onto particles
US6287285B1 (en) * 1998-01-30 2001-09-11 Advanced Cardiovascular Systems, Inc. Therapeutic, diagnostic, or hydrophilic coating for an intracorporeal medical device
US20010044030A1 (en) * 1999-05-03 2001-11-22 Guardian Industries Corporation Hydrophobic coating with DLC & FAS on substrate
US6368658B1 (en) * 1999-04-19 2002-04-09 Scimed Life Systems, Inc. Coating medical devices using air suspension
US6468642B1 (en) * 1995-10-03 2002-10-22 N.V. Bekaert S.A. Fluorine-doped diamond-like coatings
US6537310B1 (en) * 1999-11-19 2003-03-25 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal implantable devices and method of making same
US20030104028A1 (en) * 2001-11-29 2003-06-05 Hossainy Syed F.A. Rate limiting barriers for implantable devices and methods for fabrication thereof
US20030148401A1 (en) * 2001-11-09 2003-08-07 Anoop Agrawal High surface area substrates for microarrays and methods to make same
US6607908B1 (en) * 1998-10-15 2003-08-19 Toyo Kohan Co., Ltd. Supports for immobilizing DNA or the like
US20030203991A1 (en) * 2002-04-30 2003-10-30 Hydromer, Inc. Coating composition for multiple hydrophilic applications
US20040127475A1 (en) * 1999-12-29 2004-07-01 Estrogen Vascular Technology, Llc Apparatus and method for delivering compounds to a living organism
US6761736B1 (en) * 1999-11-10 2004-07-13 St. Jude Medical, Inc. Medical article with a diamond-like carbon coated polymer
US20050070936A1 (en) * 2003-09-30 2005-03-31 Pacetti Stephen D. Coatings for drug delivery devices comprising hydrolitically stable adducts of poly(ethylene-co-vinyl alcohol) and methods for fabricating the same
US20050069630A1 (en) * 2003-09-30 2005-03-31 Advanced Cardiovascular Systems, Inc. Stent mandrel fixture and method for selectively coating surfaces of a stent
US7033602B1 (en) * 2002-06-21 2006-04-25 Advanced Cardiovascular Systems, Inc. Polycationic peptide coatings and methods of coating implantable medical devices
US7491233B1 (en) * 2002-07-19 2009-02-17 Advanced Cardiovascular Systems Inc. Purified polymers for coatings of implantable medical devices

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198511A (en) * 1991-12-20 1993-03-30 Minnesota Mining And Manufacturing Company Polymerizable compositions containing olefin metathesis catalysts and cocatalysts, and methods of use therefor
US5433977A (en) * 1993-05-21 1995-07-18 Trustees Of Boston University Enhanced adherence of diamond coatings by combustion flame CVD
JPH0952707A (en) * 1995-08-08 1997-02-25 Kao Corp Production of thin film
US6110329A (en) * 1996-06-25 2000-08-29 Forschungszentrum Karlsruhe Gmbh Method of manufacturing a composite material
JPH10248923A (en) 1997-03-13 1998-09-22 San Medical Gijutsu Kenkyusho:Kk Anti-thrombus treatment of artificial heart
US6120972A (en) * 1997-09-02 2000-09-19 Jsr Corporation Radiation-sensitive resin composition
FR2777355B1 (en) * 1998-04-10 2000-05-12 Bio Merieux Method for attaching a biological molecule on the surface of a support is silica or metal oxide
WO2000010622A1 (en) * 1998-08-20 2000-03-02 Cook Incorporated Coated implantable medical device
US6638259B1 (en) * 1999-10-28 2003-10-28 Scimed Life Systems, Inc. Biocompatible medical devices
JP3786248B2 (en) * 1999-11-11 2006-06-14 東洋鋼鈑株式会社 Substrate and manufacturing method thereof chemically modified
US6379383B1 (en) * 1999-11-19 2002-04-30 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal device exhibiting improved endothelialization and method of manufacture thereof
US6953560B1 (en) * 2000-09-28 2005-10-11 Advanced Cardiovascular Systems, Inc. Barriers for polymer-coated implantable medical devices and methods for making the same
WO2002080996A1 (en) * 2001-04-03 2002-10-17 Franz Herbst Medical implant and method for producing the same
US6977138B2 (en) * 2001-07-24 2005-12-20 Massachusetts Institute Of Technology Reactive polymer coatings
US6940580B2 (en) * 2002-01-09 2005-09-06 Novartis Ag Polymeric articles having a lubricious coating and method for making the same

Patent Citations (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083570A (en) * 1987-03-31 2000-07-04 Lemelson; Jerome H. Synthetic diamond coatings with intermediate amorphous metal bonding layers and methods of applying such coatings
US5026607A (en) * 1989-06-23 1991-06-25 C. R. Bard, Inc. Medical apparatus having protective, lubricious coating
US5489303A (en) * 1991-01-25 1996-02-06 Terumo Kabushiki Kaisha Biocompatible material for medical apparatus comprising hydrophobically bound oil-soluble vitamin
US5763072A (en) * 1994-12-23 1998-06-09 Maruwa Ceramic Co., Ltd. Ceramic sliding member having pyrolytic carbon film and process of fabricating the same
US6468642B1 (en) * 1995-10-03 2002-10-22 N.V. Bekaert S.A. Fluorine-doped diamond-like coatings
US5932299A (en) * 1996-04-23 1999-08-03 Katoot; Mohammad W. Method for modifying the surface of an object
US5981297A (en) * 1997-02-05 1999-11-09 The United States Of America As Represented By The Secretary Of The Navy Biosensor using magnetically-detected label
US6197120B1 (en) * 1997-11-26 2001-03-06 3M Innovative Properties Company Apparatus for coating diamond-like networks onto particles
US6287285B1 (en) * 1998-01-30 2001-09-11 Advanced Cardiovascular Systems, Inc. Therapeutic, diagnostic, or hydrophilic coating for an intracorporeal medical device
US6607908B1 (en) * 1998-10-15 2003-08-19 Toyo Kohan Co., Ltd. Supports for immobilizing DNA or the like
US6368658B1 (en) * 1999-04-19 2002-04-09 Scimed Life Systems, Inc. Coating medical devices using air suspension
US20010044030A1 (en) * 1999-05-03 2001-11-22 Guardian Industries Corporation Hydrophobic coating with DLC & FAS on substrate
US6159531A (en) * 1999-08-30 2000-12-12 Cardiovasc, Inc. Coating having biological activity and medical implant having surface carrying the same and method
US6761736B1 (en) * 1999-11-10 2004-07-13 St. Jude Medical, Inc. Medical article with a diamond-like carbon coated polymer
US6537310B1 (en) * 1999-11-19 2003-03-25 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal implantable devices and method of making same
US20040127475A1 (en) * 1999-12-29 2004-07-01 Estrogen Vascular Technology, Llc Apparatus and method for delivering compounds to a living organism
US20030148401A1 (en) * 2001-11-09 2003-08-07 Anoop Agrawal High surface area substrates for microarrays and methods to make same
US20030104028A1 (en) * 2001-11-29 2003-06-05 Hossainy Syed F.A. Rate limiting barriers for implantable devices and methods for fabrication thereof
US20030203991A1 (en) * 2002-04-30 2003-10-30 Hydromer, Inc. Coating composition for multiple hydrophilic applications
US7033602B1 (en) * 2002-06-21 2006-04-25 Advanced Cardiovascular Systems, Inc. Polycationic peptide coatings and methods of coating implantable medical devices
US7491233B1 (en) * 2002-07-19 2009-02-17 Advanced Cardiovascular Systems Inc. Purified polymers for coatings of implantable medical devices
US20050070936A1 (en) * 2003-09-30 2005-03-31 Pacetti Stephen D. Coatings for drug delivery devices comprising hydrolitically stable adducts of poly(ethylene-co-vinyl alcohol) and methods for fabricating the same
US20050069630A1 (en) * 2003-09-30 2005-03-31 Advanced Cardiovascular Systems, Inc. Stent mandrel fixture and method for selectively coating surfaces of a stent

Cited By (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090005862A1 (en) * 2004-03-30 2009-01-01 Tatsuyuki Nakatani Stent and Method For Fabricating the Same
US20110060403A9 (en) * 2004-03-30 2011-03-10 Tatsuyuki Nakatani Stent and Method For Fabricating the Same
US8435287B2 (en) * 2004-03-30 2013-05-07 Toyo Advanced Technologies Co., Ltd. Stent and method for fabricating the same
US7763342B2 (en) 2005-03-31 2010-07-27 Tini Alloy Company Tear-resistant thin film methods of fabrication
US20140170331A1 (en) * 2006-03-29 2014-06-19 Kyocera Medical Corporation Biomaterial, joint prosthesis using the biomaterial and method of producing the same
US9034414B2 (en) * 2006-03-29 2015-05-19 Kyocera Medical Corporation Biomaterial, joint prosthesis using the biomaterial and method of producing the same
US20070246233A1 (en) * 2006-04-04 2007-10-25 Johnson A D Thermal actuator for fire protection sprinkler head
US20090209942A1 (en) * 2006-05-17 2009-08-20 Tatsuyuki Nakatani Medical device having diamond-like thin film and method for manufacturing thereof
US7931934B2 (en) * 2006-05-17 2011-04-26 Toyo Advanced Technologies Co., Ltd. Medical device having diamond-like thin film and method for manufacturing thereof
US8349099B1 (en) 2006-12-01 2013-01-08 Ormco Corporation Method of alloying reactive components
US9340858B2 (en) 2006-12-01 2016-05-17 Ormco Corporation Method of alloying reactive components
US8685183B1 (en) 2006-12-01 2014-04-01 Ormco Corporation Method of alloying reactive components
US8584767B2 (en) 2007-01-25 2013-11-19 Tini Alloy Company Sprinkler valve with active actuation
US8684101B2 (en) 2007-01-25 2014-04-01 Tini Alloy Company Frangible shape memory alloy fire sprinkler valve actuator
US20110122486A1 (en) * 2007-02-23 2011-05-26 Technische Universität Kaiserslautern Plasma-Deposited Electrically Insulating, Diffusion-Resistant and Elastic Layer System
US8007674B2 (en) 2007-07-30 2011-08-30 Tini Alloy Company Method and devices for preventing restenosis in cardiovascular stents
US20090035859A1 (en) * 2007-07-30 2009-02-05 Alfred David Johnson Method and devices for preventing restenosis in cardiovascular stents
US9192694B2 (en) 2007-10-03 2015-11-24 Kyocera Medical Corporation Biocompatible and low-abrasion member, and artificial joint using the same and method of producing the same
US20100247917A1 (en) * 2007-11-07 2010-09-30 Yuki Nitta Carbon thin film and method of forming the same
KR101505597B1 (en) * 2007-11-07 2015-03-24 토요 어드밴스드 테크놀로지스 컴퍼니 리미티드 Carbonaceous thin film and manufacturing method for the same
EP2221274A1 (en) * 2007-11-07 2010-08-25 Toyo Advanced Technologies Co., Ltd. Carbonaceous thin film and manufacturing method for same
EP2221274A4 (en) * 2007-11-07 2013-02-27 Toyo Advanced Tech Co Carbonaceous thin film and manufacturing method for same
US20090187243A1 (en) * 2007-11-30 2009-07-23 Alfred David Johnson Biocompatible copper-based single-crystal shape memory alloys
US8556969B2 (en) 2007-11-30 2013-10-15 Ormco Corporation Biocompatible copper-based single-crystal shape memory alloys
WO2009073609A1 (en) * 2007-11-30 2009-06-11 Tini Alloy Company Biocompatible copper-based single-crystal shape memory alloys
US9539372B2 (en) 2007-11-30 2017-01-10 Ormco Corporation Biocompatible copper-based single-crystal shape memory alloys
US7842143B2 (en) 2007-12-03 2010-11-30 Tini Alloy Company Hyperelastic shape setting devices and fabrication methods
US8382917B2 (en) 2007-12-03 2013-02-26 Ormco Corporation Hyperelastic shape setting devices and fabrication methods
US9127338B2 (en) 2007-12-03 2015-09-08 Ormco Corporation Hyperelastic shape setting devices and fabrication methods
US20110171817A1 (en) * 2010-01-12 2011-07-14 Axcelis Technologies, Inc. Aromatic Molecular Carbon Implantation Processes
US8350236B2 (en) * 2010-01-12 2013-01-08 Axcelis Technologies, Inc. Aromatic molecular carbon implantation processes
US9107752B2 (en) * 2010-06-28 2015-08-18 DePuy Synthes Products, Inc. Coated implant
US20130282137A1 (en) * 2010-06-28 2013-10-24 Cyril Voisard Coated implant
US20130070366A1 (en) * 2011-09-21 2013-03-21 Hitachi Global Storage Technologies Netherlands B.V. Magnetic recording head with low-wear protective film having hydrogen and/or water vapor therein
US20160281216A1 (en) * 2013-03-19 2016-09-29 Taiyo Yuden Chemical Technology Co., Ltd. Structure having stain-proofing amorphous carbon film and method of forming stain-proofing amorphous carbon film

Also Published As

Publication number Publication date Type
JP4838709B2 (en) 2011-12-14 grant
CN1938224B (en) 2011-03-30 grant
JP5226638B2 (en) 2013-07-03 grant
EP1754684A1 (en) 2007-02-21 application
JP2010005428A (en) 2010-01-14 application
US20100136212A1 (en) 2010-06-03 application
US8221823B2 (en) 2012-07-17 grant
EP1754684A4 (en) 2011-11-09 application
CA2561667C (en) 2010-04-06 grant
EP1754684B1 (en) 2016-02-03 grant
KR20070116191A (en) 2007-12-06 application
CN1938224A (en) 2007-03-28 application
WO2005097673A1 (en) 2005-10-20 application
JPWO2005097673A1 (en) 2008-02-28 application
CA2561667A1 (en) 2005-10-20 application

Similar Documents

Publication Publication Date Title
Liu et al. Surface nano-functionalization of biomaterials
Liu et al. Surface modification of titanium, titanium alloys, and related materials for biomedical applications
Beyer et al. Reduced protein adsorption on plastics via direct plasma deposition of triethylene glycol monoallyl ether
Lee et al. Interaction of cells on chargeable functional group gradient surfaces
Paital et al. Calcium phosphate coatings for bio-implant applications: materials, performance factors, and methodologies
US6131580A (en) Template imprinted materials by RFGD plasma deposition
Kulkarni et al. Titanium nanostructures for biomedical applications
US6589665B2 (en) Coated articles
US20020086160A1 (en) Process for surface modifying substrates and modified substrates resulting therefrom
Saneinejad et al. Patterned glass surfaces direct cell adhesion and process outgrowth of primary neurons of the central nervous system
US7087085B2 (en) Surface-modified implants
Vasilev et al. Tailoring the surface functionalities of titania nanotube arrays
Kodama et al. Bioactivation of titanium surfaces using coatings of TiO2 nanotubes rapidly pre-loaded with synthetic hydroxyapatite
US20090118823A1 (en) Endoprosthesis with porous reservoir
US6586038B1 (en) Process for the modification of a material surface
Zhang et al. Surface modification of stainless steel by grafting of poly (ethylene glycol) for reduction in protein adsorption
US4994298A (en) Method of making a biocompatible prosthesis
Shabalovskaya et al. Critical overview of Nitinol surfaces and their modifications for medical applications
Li et al. Protein interactions with oligo (ethylene glycol)(OEG) self-assembled monolayers: OEG stability, surface packing density and protein adsorption
Harsch et al. Pulsed plasma deposition of allylamine on polysiloxane: a stable surface for neuronal cell adhesion
US6482531B1 (en) Non-fouling, wettable coated devices
US5965629A (en) Process for modifying surfaces of materials, and materials having surfaces modified thereby
US6447920B1 (en) Organic articles
Poon et al. Carbon plasma immersion ion implantation of nickel–titanium shape memory alloys
Desai et al. Surface modification of polyethylene

Legal Events

Date Code Title Description
AS Assignment

Owner name: TOYO ADVANCED TECHNOLOGIES CO., LTD., JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ABE, YOSHINORI;NAKATANI, TATSUYUKI;OKAMOTO, KEISHI;AND OTHERS;REEL/FRAME:018399/0476;SIGNING DATES FROM 20060908 TO 20060923